跳到正文
原文
Medical Xpress·· 2026-10-19精选AI 评分63

Nature Neuroscience:FAM193B基因启动子区CCG重复与阿尔茨海默病易感性相关

Repeating stretch of DNA offers a new clue to Alzheimer's susceptibility

AI 导读

发表在Nature Neuroscience的研究在超过一万名参与者中发现,FAM193B基因启动子区的CCG三核苷酸重复长度与阿尔茨海默病风险相关。在汉族人群队列中,较长等位基因含至少18次重复者患病几率约为含不超过11次重复者的两倍。体外实验显示更长重复序列可提升FAM193B表达并增加DNA损伤标志物,但该研究仅提示关联,未确立因果关系。

推荐理由

研究将FAM193B启动子区CCG重复长度与阿尔茨海默病风险关联,并提供体外机制线索,可作为遗传易感性研究的参考依据。

正文 · 原文
older people talking
Credit: Unsplash/CC0 Public Domain

A three-letter sequence repeating along a stretch of DNA could offer new clues about why some people are more susceptible to Alzheimer's disease than others. The sequence, CCG, sits in a region of DNA that controls the gene FAM193B.

Researchers at the Hong Kong University of Science and Technology and other institutions recently explored the possibility that differences in this sequence's repetition are associated with Alzheimer's disease. Their study, published in Nature Neuroscience, linked longer repeats to higher odds of having the disease in Chinese participants, with a smaller association in people of European ancestry.

Laboratory experiments also suggested that longer repeats increase FAM193B activity, hinting at a possible link between this inherited DNA variation and processes involved in cellular damage.

Tracking CCG repeats

Many studies exploring the underpinnings of genetic susceptibility to specific diseases or disorders focus on variations at individual positions in DNA, whose four chemical bases are represented by the letters A, T, C and G. However, DNA can also present other variations, including inserted, deleted or repeated letter sequences. The researchers wanted to determine whether these structural differences could be linked to different levels of susceptibility to Alzheimer's.

Repeated sequences are difficult to reconstruct, especially when DNA sequencing machines read genetic material in short fragments. To address this problem, the researchers used longer DNA readings from 11 Chinese individuals to build a reference set of structural variants, then analyzed larger collections of short readings.

The researchers observed an apparent insertion in the promoter of the gene FAM193B, the region of DNA that controls the gene's activity. Closer examination revealed that this was a variable string of CCG repeats, with versions ranging from four repetitions to more than 30.

Segments with longer repeats were associated with Alzheimer's in a cohort of participants from Hong Kong. The team then confirmed the association in an independent mainland Chinese cohort. Together, these analyses included 1,516 people with Alzheimer's and 1,674 cognitively normal participants.

Each individual carries two copies of this DNA segment. The team found that participants whose longer copy contained at least 18 CCG repeats had approximately twice the odds of having Alzheimer's compared with those whose longer copy contained no more than 11. Notably, this comparison describes an association between groups and does not mean that an individual's lifetime probability of developing Alzheimer's doubles in the presence of more repeats.

The researchers also identified an association among UK Biobank participants of European ancestry, analyzing 2,674 clinically diagnosed cases and 22,996 controls. The association was smaller and used a different repeat-length threshold, so the estimate from the Chinese cohorts cannot simply be applied to people of other ancestries.

Repeating DNA offers a new clue to Alzheimer's susceptibility
Identification of a common AD-associated CCG repeat in the FAM193B locus. a, PacBio HiFi sequencing validation of the insertion in the FAM193B promoter region. The promoter annotation (red) was retrieved from the SCREEN database. b, Prevalence of the FAM193B-CCG repeat polymorphism in the study cohort. c, LocusZoom plot showing the associations of genetic variants in the FAM193B locus with AD. Logistic regression. Filled colors denote the linkage disequilibrium (as measured by |r|) between the FAM193B-CCG repeat and nearby genetic variants. d,e, Risk effects of the FAM193B-CCG repeat on AD with different repeat-length cutoffs in the Hong Kong Chinese cohort (d) and the mainland Chinese cohort (e). f, Meta-analysis of the risk effects of the FAM193B-CCG repeat on AD in the Chinese population. Fixed-effect meta-analysis model. g, Risk effects of the FAM193B-CCG repeat on AD with different repeat-length cutoffs in the UK Biobank. In d−g, associations were examined by logistic regression under a dominant model; data are presented as ORs with 95% CI. Black and red dotted lines indicate ORs of 1 and 2, respectively. Mb, megabase. Credit: Cao et al., Nature Neuroscience (2026).

Insights from gene activation tests

The repeats' location in the gene's control region suggested that their length might influence how strongly FAM193B is switched on. Blood analyses and the examination of donated brain tissue appeared to support this possibility, linking longer CCG repeats to higher FAM193B expression.

The researchers tested this connection in cultured human cells, comparing engineered gene-control sequences containing 11 or 25 repeats. They found that the longer version drove greater gene activity. A separate experiment showed that the sequence containing more repeats also bound more strongly to MAZ, a protein that helps regulate gene expression.

Next, the team investigated the effects of increasing FAM193B activity in cells derived from human neuroblastoma, a cancer affecting immature nerve cells. These cells developed more molecular markers of DNA damage and showed changes in the activity of genes involved in stress responses and cell death.

The results of this study hint at a possible connection between increased FAM193B activity and cellular harm. However, they do not establish that longer repeats damage neurons in people or explain the full association of CCG repeats with Alzheimer's.

Although FAM193B is active in many tissues, the researchers write that "its biological function remains unclear." Future studies could try to establish how increased activity affects neurons, which could help to understand why this repeating stretch of DNA is linked with Alzheimer's susceptibility.

Written for you by our author Ingrid Fadelli, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.

Publication details

Han Cao et al., Genome-wide analysis of common structural variants in Alzheimer's disease identifies a risk-associated regulatory CCG repeat in FAM193B, Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02481-z

Journal information: Nature Neuroscience

Who's behind this story?

Ingrid Fadelli

Ingrid Fadelli

Freelance journalist with BSc Psychology and MA International Journalism. Covers AI, robotics, neuroscience, and astrophysics since 2018. Full profile →

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

© 2026 Science X Network

Citation: Repeating stretch of DNA offers a new clue to Alzheimer's susceptibility (2026, October 19) retrieved 19 October 2026 from https://medicalxpress.com/news/2026-10-dna-clue-alzheimer-susceptibility.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com